Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
N-Acetylglucosaminyltransferase V (GnT-V), an enzyme that catalyzes the β1-6 branching of N-acetylglucosamine on asparagine-linked oligosaccharides of cellular proteins, enhances the malignant behaviors of carcinoma cells in experimental models. The aim of this study was to determine clinical significance of GnT-V expression in human pT2 gallbladder carcinoma with simple in vitro experiments.
Ninety patients with pT2 gallbladder carcinoma were included for this study. The in vitro and in vivo biological effects of GnT-V were investigated using gallbladder carcinoma cells with variable GnT-V expression levels induced by a small interfering RNA.
Of the 90 cases, 57 showed positive staining and the remaining 33 demonstrated negative staining, the subcellular localization in the 57 cases was classified into the granular-type in 31 cases and the diffuse-type in 26 cases. In 76 cases with curative resection, postsurgical survival was significantly poorer in those showing positive staining than in those showing negative staining (P = 0.028). In all of the 76 cases, postsurgical recurrence was significantly more frequent in those showing diffuse-type localization than in those showing negative staining. Experimental analyses demonstrated that the down-regulation of GnT-V expression in gallbladder carcinoma cells induced suppression of cell growth in vitro. The expression levels of GnT-V in the cells were highly correlated with the rapid in vivo growth coupled with the enhanced angiogenesis, and the tendency to form liver metastasis.
GnT-V expression in the subserosal layer of pT2 gallbladder carcinoma is correlated with the aggressiveness of the disease.
- Ruckert JC, Ruckert RI, Gellert K, Hecker K, Muller JM. Surgery for carcinoma of the gallbladder. Hepatogastroenterology. 1996;43:527–33.
- Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg. 1994;219:275–80.
- Oertli D, Herzog U, Tondelli P. Primary carcinoma of the gallbladder: operative experience during a 16-year period. Eur J Surg. 1993;159:415–20.
- Gall FP, Kockerling F, Scheele J, Schneider C, Hohenberger W. Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg. 1991;15:328–36.
- Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg. 1990;125:237–41.
- Ouchi K, Owada Y, Matsuno S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery. 1987;101:731–7.
- Yamaguchi K, Chijiiwa K, Saiki S, Nishihara K, Takashima M, Kawakami K, et al. Retrospective analysis of 70 operations for gallbladder carcinoma. Br J Surg. 1997;84:200–4.
- Todoroki T, Kawamoto T, Takahashi Y, Takada Y, Koike N, Otsuka M, et al. Treatment of gallbladder cancer by radical resection. Br J Surg. 1999;86:622–7.
- Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, et al. Expression of MUC1 mucins in the subserosal layer correlates with post-surgical prognosis of pT2 carcinoma of the gallbladder. Clin Cancer Res. 2001;7:1333–42.
- Hart GW, Copeland RJ. Glycomics hits the big time. Cell. 2010;143:672–6.
- Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. Beta 1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science. 1987;236:582–5.
- Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, et al. N-Acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res. 1993;53:3899–902.
- Lau KS, Dennis JW. N-glycans in cancer progression. Glycobiology. 2008;18:750–60.
- Granovsky M, Fata J, Pawling J, Muller WJ, Khokaha R, Dennis JW. Supression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 2000;6:306–12.
- Dennis JW, Nabi IR, Demetriou M. Metabolism, cell surface organization, and disease. Cell. 2009;139:1229–41.
- Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, et al. Prometastatic effect of N-Acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1–6 GlcNAc branching. J Biol Chem. 2002;277:16960–7.
- Saito T, Miyoshi E, Sasai K, Nakano N, Eguchi H, Honke K, et al. A secreted type of beta 1,6-N-Acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity. J Biol Chem. 2002;277:17002–8.
- Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, et al. Expression of N-Acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res. 2000;6:1772–7.
- Perng GS, Shoreibah M, Margitich I, Pierce M, Fregien N. Expression of N-Acetylglucosaminyltransferase V mRNA in mammalian tissues and cell lines. Glycobiology. 1994;4:867–71.
- Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H, Taniguchi N. Expression of N-Acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res. 2004;10:1773–9.
- Ishimura H, Takahashi T, Nakagawa H, Nishimura S, Arai Y, Horikawa Y, et al. N-Acetylglucosaminyltransferase V and beta 1–6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res. 2006;12:2506–11.
- Handerson T, Pawelek JM. Beta 1,6-branched oligosaccharides and coarse vesicles: a common, pervasive phenotype in melanoma and other human cancers. Cancer Res. 2003;63:5363–9.
- Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O’sullivan B, Sobin LH, Yarbro JW, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
- Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, et al. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol. 1985;1:579–96.
- Koike N, Todoroki T, Kawamoto T, Yoshida S, Kashiwagi H, Fukao K, et al. The invasion potentials of human biliary tract carcinoma cell lines: correlation between invasiveness and morphologic characteristics. Int J Oncol. 1998;13:1269–74.
- Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, et al. Expression of UDP-N-Acetyl-alpha-d-galactosamine-polypeptide N-Acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res. 2004;10:2090–9.
- Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
- Inamori K, Gu J, Ohira M, Kawasaki A, Nakamura Y, Nakagawa T, et al. High expression of N-Acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apotosis. FEBS Lett. 2006;580:627–32.
- Nabekura T, Otsu M, Nagasawa T, Nakauchi H, Onodera M. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. Mol Ther. 2006;13:301–9.
- Suzuki A, Obi K, Urabe T, Hayakawa H, Yamada M, Kaneko S, et al. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem. 2002;82:953–60.
- Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y. Implication of N-Acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta. 1999;1455:287–300.
- Ichihara H, Funamoto K, Matsushita T, Matsumoto Y, Ueoka R. Histological bioanalysis for therapeutic effects of hybrid liposomes on the hepatic metastasis of colon carcinoma in vivo. Int J Pharm. 2010;394:174–8.
- Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–21.
- Matsushita Y, Cleary KR, Ota DM, Hoff SD, Irimura T. Syalyl-dimetric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastasis. Lab Invest. 1990;63:780–91.
- Kawamoto T, Shoda J, Miyahara N, Suzuki H, Furukawa M, Todoroki T, et al. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder. Clin Exp Metastasis. 2004;21:353–62.
- Zhang K, Baeckstrom D, Brevinge H, Hansson GC. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialylLewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem. 1996;60:538–49.
- Treon SP, Maimonis P, Bua D, Young G, Raje N, Mollick J, et al. Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple melanoma. Blood. 2000;96:3147–53.
- Thathiah A, Blobel CP, Carson DD. Tumor necrosis factor-α converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem. 2003;278:3386–94.
- Taatjes DJ, Roth J, Weinstein J, Paulson JC, Shaper NL, Shaper JH. Codistribution of galactosyl- and sialyltransferase: reorganization of trans Golgi apparatus elements in hepatocytes in intact liver and cell culture. Eur J Cell Biol. 1987;44:187–94.
- Pierce M, Buckhaults P, Chen L, Fregien N. Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta (1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J. 1997;14:623–30.
- Ujita M, McAuliffe J, Hindsgaul O, Sasaki K, Fukuda MN, Fukuda M. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of I-extension enzyme and beta1, 4-galactosyltransferase I. J Biol Chem. 1999;274:16717–26.
- Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992;267:5700–11.
- Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, et al. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993;53:3632–7.
- Shimodaira K, Nakayama J, Nakamura N, Hasebe O, Katsuyama T, Fukuda M. Carcinoma-associated expression of core 2 beta-1,6-N-Acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res. 1997;57:5201–6.
- Nakahara S, Saito T, Kondo N, Moriwaki K, Noda K, Ihara S, et al. A secreted type of β1,6 N-acetylglucosaminyltransferase V (GnT-V), a novel angiogenesis inducer, is regulated by γ-secretase. FASEB J. 2006;20:2451–9.
- Dennis JW. Effects of swainsonine and polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res. 1986;46:5131–6.
- Goss PE, Reid CL, Bailey D, Dennis JW. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonone in patients with advanced malignancies. Clin Cancer Res. 1997;3:1077–86.
- Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder
Journal of Gastroenterology
Volume 49, Issue 4 , pp 702-714
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Gallbladder carcinoma
- N-Acetylglucosaminyltransferase V
- Malignant behavior
- Postsurgical prognosis
- Tumor cell biology
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan
- 2. Department of Gastroenterology, Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
- 3. Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan
- 4. Department of Infection Biology, Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
- 5. Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
- 6. Department of Genetics, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan
- 7. Department of Oral and Maxillofacial Surgery, Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
- 8. Medical Science, Division of Clinical Science, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan